GW Henssler & Associates Ltd. Has $10.39 Million Holdings in Amdocs Limited $DOX

Key Points

• GW Henssler & Associates Ltd. increased its holdings in Amdocs Limited by 9.3%, owning a total of 113,895 shares valued at approximately $10.39 million.
• Analysts have set a consensus rating of "Moderate Buy" for Amdocs, with an average target price of $108.00.
• Amdocs declared a quarterly dividend of $0.527 per share, representing an annualized dividend yield of 2.6%, to be paid on October 31st.

GW Henssler & Associates Ltd. raised its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 9.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 113,895 shares of the technology company's stock after purchasing an additional 9,705 shares during the period. GW Henssler & Associates Ltd. owned 0.10% of Amdocs worth $10,392,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. LSV Asset Management increased its stake in shares of Amdocs by 11.1% in the 1st quarter. LSV Asset Management now owns 3,180,501 shares of the technology company's stock valued at $291,016,000 after acquiring an additional 317,412 shares during the last quarter. Alyeska Investment Group L.P. increased its stake in shares of Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock valued at $213,174,000 after acquiring an additional 648,693 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock valued at $205,219,000 after acquiring an additional 426,911 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Amdocs by 9.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,120,075 shares of the technology company's stock valued at $193,978,000 after acquiring an additional 182,489 shares during the last quarter. Finally, AQR Capital Management LLC increased its stake in shares of Amdocs by 43.0% in the 1st quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company's stock valued at $86,719,000 after acquiring an additional 287,243 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on DOX shares. Wolfe Research started coverage on Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating for the company. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Amdocs in a research note on Wednesday. Finally, Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $108.00.

Amdocs Price Performance

NASDAQ DOX opened at $80.77 on Friday. The business has a 50 day simple moving average of $84.82 and a 200 day simple moving average of $87.71. Amdocs Limited has a 52-week low of $78.61 and a 52-week high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. The stock has a market cap of $9.12 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 1.34 and a beta of 0.51.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.Amdocs's revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.62 EPS. Analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is currently 42.60%.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.